BIOMAT Database Logo BIOMAT Database Logo

Excess release of hypoxanthine from exercising muscle in two gout patients with partial HGPRTase deficiency: lack of ammonium release. 1991

I Hisatome, and H Kitamura, and M Saito, and T Kinugawa, and H Miyakoda, and H Kotake, and H Mashiba, and T Azumi, and K Ohno, and A Takeda

UI MeSH Term Description Entries
D007041 Hypoxanthine Phosphoribosyltransferase An enzyme that catalyzes the conversion of 5-phosphoribosyl-1-pyrophosphate and hypoxanthine, guanine, or MERCAPTOPURINE to the corresponding 5'-mononucleotides and pyrophosphate. The enzyme is important in purine biosynthesis as well as central nervous system functions. Complete lack of enzyme activity is associated with the LESCH-NYHAN SYNDROME, while partial deficiency results in overproduction of uric acid. EC 2.4.2.8. Guanine Phosphoribosyltransferase,HPRT,Hypoxanthine-Guanine Phosphoribosyltransferase,IMP Pyrophosphorylase,HGPRT,HPRTase,Hypoxanthine Guanine Phosphoribosyltransferase,Phosphoribosyltransferase, Guanine,Phosphoribosyltransferase, Hypoxanthine,Phosphoribosyltransferase, Hypoxanthine-Guanine,Pyrophosphorylase, IMP
D007042 Hypoxanthines Purine bases related to hypoxanthine, an intermediate product of uric acid synthesis and a breakdown product of adenine catabolism.
D008297 Male Males
D009132 Muscles Contractile tissue that produces movement in animals. Muscle Tissue,Muscle,Muscle Tissues,Tissue, Muscle,Tissues, Muscle
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005080 Exercise Test Controlled physical activity which is performed in order to allow assessment of physiological functions, particularly cardiovascular and pulmonary, but also aerobic capacity. Maximal (most intense) exercise is usually required but submaximal exercise is also used. Arm Ergometry Test,Bicycle Ergometry Test,Cardiopulmonary Exercise Testing,Exercise Testing,Step Test,Stress Test,Treadmill Test,Cardiopulmonary Exercise Test,EuroFit Tests,Eurofit Test Battery,European Fitness Testing Battery,Fitness Testing,Physical Fitness Testing,Arm Ergometry Tests,Bicycle Ergometry Tests,Cardiopulmonary Exercise Tests,Ergometry Test, Arm,Ergometry Test, Bicycle,Ergometry Tests, Arm,Ergometry Tests, Bicycle,EuroFit Test,Eurofit Test Batteries,Exercise Test, Cardiopulmonary,Exercise Testing, Cardiopulmonary,Exercise Tests,Exercise Tests, Cardiopulmonary,Fitness Testing, Physical,Fitness Testings,Step Tests,Stress Tests,Test Battery, Eurofit,Test, Arm Ergometry,Test, Bicycle Ergometry,Test, Cardiopulmonary Exercise,Test, EuroFit,Test, Exercise,Test, Step,Test, Stress,Test, Treadmill,Testing, Cardiopulmonary Exercise,Testing, Exercise,Testing, Fitness,Testing, Physical Fitness,Tests, Arm Ergometry,Tests, Bicycle Ergometry,Tests, Cardiopulmonary Exercise,Tests, EuroFit,Tests, Exercise,Tests, Step,Tests, Stress,Tests, Treadmill,Treadmill Tests
D006010 Glycogen Storage Disease Type III An autosomal recessive metabolic disorder due to deficient expression of amylo-1,6-glucosidase (one part of the glycogen debranching enzyme system). The clinical course of the disease is similar to that of glycogen storage disease type I, but milder. Massive hepatomegaly, which is present in young children, diminishes and occasionally disappears with age. Levels of glycogen with short outer branches are elevated in muscle, liver, and erythrocytes. Six subgroups have been identified, with subgroups Type IIIa and Type IIIb being the most prevalent. Cori's Disease,Debrancher Deficiency,Forbes Disease,Glycogen Debranching Enzyme Deficiency,Glycogenosis 3,Limit Dextrinosis,Amylo-1,6-Glucosidase Deficiency,Cori Disease,Deficiency, Debrancher,Glycogen Debrancher Deficiency,Glycogen Storage Disease III,Glycogen Storage Disease Type 3,Amylo 1,6 Glucosidase Deficiency,Amylo-1,6-Glucosidase Deficiencies,Coris Disease,Debrancher Deficiencies,Debrancher Deficiencies, Glycogen,Debrancher Deficiency, Glycogen,Deficiencies, Amylo-1,6-Glucosidase,Deficiencies, Debrancher,Deficiencies, Glycogen Debrancher,Deficiency, Amylo-1,6-Glucosidase,Deficiency, Glycogen Debrancher,Dextrinoses, Limit,Dextrinosis, Limit,Disease, Cori,Disease, Cori's,Disease, Forbes,Glycogen Debrancher Deficiencies,Glycogenosis 3s,Limit Dextrinoses
D006073 Gout Metabolic disorder characterized by recurrent acute arthritis, hyperuricemia and deposition of sodium urate in and around the joints, sometimes with formation of URIC ACID calculi. Gouts
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

I Hisatome, and H Kitamura, and M Saito, and T Kinugawa, and H Miyakoda, and H Kotake, and H Mashiba, and T Azumi, and K Ohno, and A Takeda
Excess release of hypoxanthine from exercising muscle in patients with Kearns-Sayre syndrome.
April 1993, Muscle & nerve,
I Hisatome, and H Kitamura, and M Saito, and T Kinugawa, and H Miyakoda, and H Kotake, and H Mashiba, and T Azumi, and K Ohno, and A Takeda
Normal hypoxanthine and ammonia release from working muscle in partial HPRT deficiency.
January 1994, Advances in experimental medicine and biology,
I Hisatome, and H Kitamura, and M Saito, and T Kinugawa, and H Miyakoda, and H Kotake, and H Mashiba, and T Azumi, and K Ohno, and A Takeda
Exercising muscle does not produce hypoxanthine in adenylate deaminase deficiency.
June 1983, Neurology,
I Hisatome, and H Kitamura, and M Saito, and T Kinugawa, and H Miyakoda, and H Kotake, and H Mashiba, and T Azumi, and K Ohno, and A Takeda
[Properties of hypoxanthineguanine-phosphoribosyltransferase (HGPRTase) in a gout patient with partial deficiency of this enzyme (author's transl)].
January 1979, Klinische Wochenschrift,
I Hisatome, and H Kitamura, and M Saito, and T Kinugawa, and H Miyakoda, and H Kotake, and H Mashiba, and T Azumi, and K Ohno, and A Takeda
Enhanced release of ammonia and hypoxanthine from exercising muscles in patients with idiopathic hypoparathyroidism.
September 1987, Muscle & nerve,
I Hisatome, and H Kitamura, and M Saito, and T Kinugawa, and H Miyakoda, and H Kotake, and H Mashiba, and T Azumi, and K Ohno, and A Takeda
Partial deficiency of hypoxanthine-guanine phosphoribosyltransferase associated with gout and uric acid lithiasis.
November 1970, Revue europeenne d'etudes cliniques et biologiques. European journal of clinical and biological research,
I Hisatome, and H Kitamura, and M Saito, and T Kinugawa, and H Miyakoda, and H Kotake, and H Mashiba, and T Azumi, and K Ohno, and A Takeda
Partial deficiency of hypoxanthine-phosphoribosyltransferase:evidence for a structural mutation in a patient with gout.
February 1979, European journal of clinical investigation,
I Hisatome, and H Kitamura, and M Saito, and T Kinugawa, and H Miyakoda, and H Kotake, and H Mashiba, and T Azumi, and K Ohno, and A Takeda
Hypoxanthine-guanine phosphoribosyltransferase deficiency in gout.
January 1969, Annals of internal medicine,
I Hisatome, and H Kitamura, and M Saito, and T Kinugawa, and H Miyakoda, and H Kotake, and H Mashiba, and T Azumi, and K Ohno, and A Takeda
Allopurinol-induced arteritis in partial HGPRTase deficiency. Atypical seizure manifestation.
November 1978, Archives of internal medicine,
I Hisatome, and H Kitamura, and M Saito, and T Kinugawa, and H Miyakoda, and H Kotake, and H Mashiba, and T Azumi, and K Ohno, and A Takeda
Release of hypoxanthine and phosphate from exercising human legs with and without arterial insufficiency.
January 1982, Acta medica Scandinavica,
Copied contents to your clipboard!